SOD1 and amyotrophic lateral sclerosis: Wang et al., also found that in ALS hSOD1 mutant models, fisetin therapy offered neuroprotection with enhanced neuronal survival, reduced motor dysfunction, decreased ROS level, and controlled redox homeostasis.